| HCPCS Code | Code Dosage | Payment Limit |
Vaccine AWP % | Vaccine Limit | Infusion AWP % | DME infusion limit | Blood AWP % | Blood limit | Clotting factor | Note |
|---|---|---|---|---|---|---|---|---|---|---|
J9047 - Injection, carfilzomib, 1 mg |
1 MG | 39.345 | - | - | - | - | - | - | ||
J9050 - Injection, carmustine, 100 mg |
100 MG | 1743.245 | - | - | - | - | - | - | ||
J9055 - Injection, cetuximab, 10 mg |
10 MG | 65.483 | - | - | - | - | - | - | ||
J9060 - Injection, cisplatin, powder or solution, 10 mg |
10 MG | 1.681 | - | - | - | - | - | - | ||
J9065 - Injection, cladribine, per 1 mg |
1 MG | 21.023 | - | - | - | - | - | - | ||
J9070 - Cyclophosphamide, 100 mg |
100 MG | 31.164 | - | - | - | - | - | - | ||
J9100 - Injection, cytarabine, 100 mg |
100 MG | 0.692 | - | - | - | - | - | - | ||
J9119 - Injection, cemiplimab-rwlc, 1 mg |
1 MG | 27.397 | - | - | - | - | - | - | ||
J9120 - Injection, dactinomycin, 0.5 mg |
0.5 MG | 934.158 | - | - | - | - | - | - | ||
J9130 - Dacarbazine, 100 mg |
100 MG | 4.846 | - | - | - | - | - | - | ||
J9144 - Injection, daratumumab, 10 mg and hyaluronidase-fihj |
10 MG | 43.851 | - | - | - | - | - | - | ||
J9145 - Injection, daratumumab, 10 mg |
10 MG | 56.037 | - | - | - | - | - | - | ||
J9150 - Injection, daunorubicin, 10 mg |
10 MG | 42.52 | - | - | - | - | - | - | ||
J9153 - Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine |
1 MG/2.27 MG | 201.686 | - | - | - | - | - | - | ||
J9155 - Injection, degarelix, 1 mg |
1 MG | 3.89 | - | - | - | - | - | - | ||
J9171 - Injection, docetaxel, 1 mg |
1 MG | 0.72 | - | - | - | - | - | - | ||
J9173 - Injection, durvalumab, 10 mg |
10 MG | 77.052 | - | - | - | - | - | - | ||
J9176 - Injection, elotuzumab, 1 mg |
1 MG | 6.673 | - | - | - | - | - | - | ||
J9177 - Injection, enfortumab vedotin-ejfv, 0.25 mg |
0.25 MG | 27.958 | - | - | - | - | - | - | ||
J9178 - Injection, epirubicin hcl, 2 mg |
2 MG | 1.51 | - | - | - | - | - | - | ||
J9179 - Injection, eribulin mesylate, 0.1 mg |
0.1 MG | 117.762 | - | - | - | - | - | - | ||
J9181 - Injection, etoposide, 10 mg |
10 MG | 0.744 | - | - | - | - | - | - | ||
J9185 - Injection, fludarabine phosphate, 50 mg |
50 MG | 47.529 | - | - | - | - | - | - | ||
J9190 - Injection, fluorouracil, 500 mg |
500 MG | 1.684 | - | - | - | - | - | - | ||
J9200 - Injection, floxuridine, 500 mg |
500 MG | 70.126 | - | - | - | - | - | - | ||
| * Effective January 1, 2021 through March 31, 2021 | ||||||||||
Medicare Part B payment allowance limits for drugs not otherwise classified - Effective January 1, 2021 through March 31, 2021
| Drug name | Dosage | Payment limit | Notes |
|---|---|---|---|
| Alfentanil Hcl | 500 MCG | 1.917 | |
| Allopurinol Sodium | 500 MG | 3149.724 | |
| Aminocaproic acid | 250 MG | 0.341 | |
| Aztreonam | 500 MG | 12.574 | |
| Bumetanide | 0.25 MG | 0.354 | |
| Bupivacaine | 1 ML | 0.064 | |
| Clindamycin Phosphate | 150 MG | 0.89 | |
| Coagulation Factor IX, Recombinant (Ixinity) | 1 IU | 1.737 | includes clotting factor furnishing fee |
| Diltiazem Hydrochloride | 5 MG | 0.331 | |
| Doxycycline Hyclate | 100 MG | 18.736 | |
| Esmolol Hydrochloride | 10 MG | 0.33 | |
| Famotidine | 10 MG | 0.389 | |
| Flumazenil | 0.1 MG | 0.683 | |
| Folic Acid | 5 MG | 2.638 | |
| Glucarpidase | 10 UNITS | 328.863 | |
| Glycopyrrolate injection | 0.2 MG | 2.399 | |
| Immune Globulin (Asceniv) | 500 MG | 481.77 | |
| Immune Globulin (Cutaquig) | 100 MG | 18.184 | |
| Immune Globulin (Panzyga) | 500 MG | 64.513 | |
| Labetalol Hcl | 5 MG | 0.151 | |
| Metoprolol Tartrate | 1 MG | 0.123 | |
| Metronidazole inj | 500 MG | 1.221 | |
| Nitroglycerin | 5 MG | 1.255 | |
| Olanzapine short acting intramuscular injection | 0.5 MG | 1.263 | |
| Paliperidone Palmitate (Invega Trinza) | 1 MG | 10.195 | |
| Rabies Immune Globulin (Kedrab) | 150 IU | 231.649 | |
| Rifampin | 600 MG | 104.387 | |
| Sodium Chloride, Hypertonic (3% - 5% infusion) | 250 CC | 1.464 | |
| Sulfamethoxazole-Trimethoprim | 400-80 MG | 0.627 | |
| Vasopressin | 20 UNITS | 203.34 |
AMP-based payment limit
Added January 2021